Carisma Therapeutics, Inc. (CARM)
OTCMKTS · Delayed Price · Currency is USD
0.0005
0.00 (0.00%)
At close: May 5, 2026
Carisma Therapeutics Market Cap
Carisma Therapeutics has a market cap or net worth of $20.92 thousand as of May 5, 2026. Its market cap has decreased by -99.74% in one year.
Market Cap
20.92K
Enterprise Value
-1.99M
Revenue
52.63M
Ranking
n/a
PE Ratio
0.00
Stock Price
$0.00
Market Cap Chart
Since March 8, 2023, Carisma Therapeutics's market cap has decreased from 147.73M to 20.92K, a decrease of -99.99%. That is a compound annual growth rate of -93.94%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 5, 2026 | 20.92K | -98.84% |
| Dec 31, 2025 | 1.80M | -89.71% |
| Dec 31, 2024 | 17.48M | -85.21% |
| Dec 29, 2023 | 118.25M | -19.96% |
| Mar 8, 2023 | 147.73M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nascent Biotech | 34.57K |
| Scorpius Holdings | 30.57K |
| America Great Health | 21.15K |
| Health Sciences Group | 20.51K |
| Entia Biosciences | 20.44K |
| Scopus BioPharma | 16.83K |
| NanoLogix | 16.29K |
| Regenicin | 15.35K |